Bulletin
Investor Alert

New York Markets Close in:

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Market open

 --Real time quotes

May 27, 2022, 1:49 p.m.

/zigman2/quotes/205619834/composite

$

147.79

Change

+11.99 +8.83%

Volume

Volume 4.85m

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 135.80

$ 147.79

Change

+11.99 +8.83%

Day low

Day high

$136.59

$148.12

Open

52 week low

52 week high

$119.01

$497.49

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Melanie Ivarsson
Chief Development Officer
Dr. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Jonathan Hoggatt
Director-Hematology
Mr. Michael Mullette
Managing Director-Canada
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Paula Hammond
Scientific Advisory Board
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.